Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor α in response to HLA-A2.1-binding melanoma and viral peptide antigens

Journal of Immunological Methods

Volumn 191, Issue 2, 1996, Pages 131-142

  Herr, Wolfgang ^a   Schneider, Jörg ^a   Lohse, Ansgar W ^a   Meyer Zum Büschenfelde, Karl Hermann ^a   Wölfel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CD8+ lymphocyte; ELISPOT assay; HIV; HLA A2.1; Melanoma antigen; Tumor necrosis factor

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MELANOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029953952     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00007-5     Document Type: Article

References (52)

1. Bakker, A.B.H., Schreurs, M.W.J., De Boer, A.J., Kawakami, Y., Rosenberg, S.A., Adema, G.J. and Figdor, C.G. (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes, J. Exp. Med. 179, 1005.
2. Boel, P., Wildmann, C., Sensi, M.L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T. and Van der Bruggen, P. (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2, 167.
3. Bouchard, B., Fuller, B.B., Vijayasaradhi, S. and Houghton, A.N. (1989) Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169, 2029.
4. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P. and Boon, T. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lympocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489.
5. Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L. (1993) Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Different CTL responses to HIV-1 and Epstein-Barr Virus in late disease. J. Exp. Med. 177, 249.
6. Cerundolo, V., Alexander, J., Anderson, K., Lamb, C., Cresswell, P., McMichael, A., Gotch, F. and Townsend, A. (1990) Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345, 449.
7. Cohen, I.R. (1992) The cognitive paradigm and the immunological homunculus. Immunol. Today 13, 490.
8. Cohen, J. (1994) Vaccines get a new twist. Science 264, 503.
9. Coulie, P., Somville, M., Lehmann, F., Hainaut, P., Brasseur, F., Devos, R. and Boon, T. (1992) Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int. J. Cancer 50, 289.
10. Coulie, P., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J.-P., Renauld, J.-C. and Boon, T. (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35.
11. Czerkinsky, C., Andersson, G., Ekre, H.-P., Nilsson, L.-A. and Ouchterlony, Ö. (1988) Reverse ELISPOT assay for clonal analysis of cytokine production, I, Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 115, 31.
12. De Bergeyck, V., De Plaen, E., Chomez, P., Boon, T. and Van Pel, A. (1994) An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur. J. Immunol. 24, 2203.
13. Exley, A.R. and Cohen, J. (1990) Optimal collection of blood samples for the measurement of tumor necrosis factor alpha. Cytokine 2, 353.
14. Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J.J., De Plaen, E., Lethé, B., Brasseur, F. and Boon, T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921.
15. Henderson, R.A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D.F. and Engelhard, V.H. (1992) HLA-A2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation. Science 255, 1264.
16. Herr, W., Wölfel, T., Heike, M., Meyer zum Büschenfelde, K.-H. and Knuth, A. (1994) Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells. Cancer Immunol. Immunother. 39, 93.
17. Houbiers, J.G., Nijman, H.W., Van der Burg, S.H., Drijfhout, J.W., Kenemans, P., Van de Velde, C.J., Brand, A., Momburg, F., Kast, W.M. and Melief, C.J. (1993) In vitro induction of human cytotoxic T lymphocytes responses against peptides of mutant and wild-type p53. Eur. J. Immunol. 23, 2072.
18. Kabilan, L., Andersson, G., Lolli, F., Ekre, H.-P., Olsson, T. and Troye-Blomberg, M. (1990) Detection of intracellular expression and secretion of interferon-γ at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur. J. Immunol. 20, 1085.
19. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Sakaguchi, K., Appella, E., Yannelli, J.R., Adema, G.J., Miki, T. and Rosenberg, S.A. (1994a) Identification of a human melanoma antigen recognized by tumor-in filtrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458.
20. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P.F., Rivoltini, L., Yanelli, J.R., Appella, E. and Rosenberg, S.A. (1994b) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 180, 347.
21. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P.F., Sette, A., Appella, E. and Rosenberg, S.A. (1995) Recognition of multiple epitopes in the human melanoma antigen gplOO by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154, 3961.
22. Knuth, A., Danowski, B., Oettgen, H.F. and Old, L.J. (1984) T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T cell cultures. Proc. Natl. Acad. Sci. USA 81, 3511.
23. Knuth, A., Wölfel, T. and Meyer zum Büschenfelde, K.H. (1992) T cell responses to human malignant tumors. Cancer Surv. 13, 39.
24. Livingston, P.O., Shiku, H., Bean, M.A., Pinsky, C.M., Oettgen, H.F. and Old, L.J. (1979) Cell-mediated cytotoxicity for cultured autologous melanoma cells. Int. J. Cancer 24, 34.
25. Mahanty, S., Abrams, J.S., King, C.L., Limaye, A.P. and Nutman, T.B. (1992) Parallel regulation of IL-4 and IL-5 in human helminth infections. J. Immunol. 148, 3567.
26. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M. and Eisenbach, L. (1994) CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369, 67.
27. Maryanski, J.L. and Boon, T. (1982) Immunogenic variants obtained by mutagenesis of mouse mastocytome P815. IV: Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. Eur. J. Immunol. 12, 406.
28. + T cells using an ELISPOT assay. J. Immunol. Methods 181, 45.
29. Monach, P.A., Meredith, S.C., Siegel, C.T. and Schreiber, H. (1995) A unique tumor antigen produced by a single amino acid substitution. Immunity 2, 45.
30. Nanda, N.K. and Sercarz, E.E. (1995) Induction of anti-self-immunity to cure cancer. Cell 82, 13.
31. Nijman, H.W., Houbiers, J.G.A., Vierboom, M.P.M., Van der Burg, S.H., Drijfhout, J.W., Amaro, J., Kenemans, P., Melief, C.J.M. and Kast, W.M. (1993) Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1215.
32. Nowak, M.A., May, R.M., Phillips, R.E., Rowland-Jones, S., Lalloo, D.G., McAdam, S., Klenerman, P., Köppe, B., Sigmund, K., Bangham, C.R.M. and McMichael, A.J. (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375, 606.
33. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P.F., Marincola, F.M., Salgaller, M.L., Yannelli, J.R., Appella, E., and Rosenberg, S.A. (1995) Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154, 2257.
34. Robbins, P.F., El-Gamil, M., Kawakami, Y. and Rosenberg, S.A. (1994) Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54, 3124.
35. + T and B cell epitopes. J. Immunol. 153, 4636.
36. Salter, R.D., Howell, D.M. and Cresswell, P. (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21, 235.
37. Sharrock, C.E.M., Kaminski, E. and Man, S. (1990) Limiting dilution analysis of human T cells: a useful clinical tool. Immunol. Today 11, 281.
38. Specter, S., Cerdan, A., Cerdan, C., Chang, K. and Friedman, H. (1984) Cell-mediated immune responsiveness to cardiac extracts by peripheral blood leukocytes from patients after myocardial infarction or open-heart surgery. Clin. Immunol. Immunopathol. 30, 19.
39. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA 91, 9461.
40. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Nail. Acad. Sci. USA 88, 11276.
41. Tsukaguchi, K., Balaji, K.N. and Boom, W.H. (1995) CD4+ αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. J. Immunol. 154, 1786.
42. Van den Eynde, B., Lethe, B., Van Pel, A., De Plaen, E. and Boon, T. (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173, 1373.
43. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. and Boon, T. (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689.
44. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C. De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643.
45. Visseren, M.J.W., Van Elsas, A., Van der Voort, E.I.H., Ressing, M.E., Kast, W.M., Schrier, P.I. and Melief, C.J.M. (1995) CTL specific for tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154, 3991.
46. Wang, R.F., Robbins, P.F., Kawakami, Y., Kang, X.Q. and Rosenberg, S.A. (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181, 799.
47. Ward, P.L., Koeppen, H., Hurteau, T. and Schreiber, H. (1989) Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170, 217.
48. Wei, M.L. and Cresswell, P. (1992) HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356, 443.
49. Wölfel, T., Hauer, M., Klehmann, E., Brichard, V., Ackermann, B., Knuth, A., Boon, T. and Meyer zum Büschenfelde, K.-H. (1993) Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer 55, 237.
50. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger B., Meyer zum Büschenfelde, K.-H. and Boon, T. (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24, 759.
51. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281.
52. Yi, Q. and Lefvert, A.K. (1992) Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis. J. Immunol. 149, 3423.